MAPT and Alzheimer disease: These four sites of tau are involved in AD by misbalancing the kinases metabolism by activating phosphorylase kinase (PK), casein kinase 1 δ (CK1 δ), and/or glycogen synthase kinase-3 (GSK-3) [16].